Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Liabilities and Shareholders Equity (2020 - 2025)

Bio Essence (BIOE) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $184534.0 in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 74.23% year-over-year to $184534.0; the TTM value through Sep 2025 reached $943968.0, down 87.94%, while the annual FY2024 figure was $281024.0, 89.81% down from the prior year.
  • Liabilities and Shareholders Equity reached $184534.0 in Q3 2025 per BIOE's latest filing, up from $112692.0 in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.8 million in Q4 2023 and bottomed at $112692.0 in Q2 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $1.4 million, with a median of $1.7 million recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 78.23% in 2023, then tumbled 94.62% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 million in 2021, then dropped by 8.92% to $1.5 million in 2022, then soared by 78.23% to $2.8 million in 2023, then crashed by 89.81% to $281024.0 in 2024, then crashed by 34.34% to $184534.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $184534.0 in Q3 2025, $112692.0 in Q2 2025, and $365718.0 in Q1 2025.